Forecast: Diabetes Medicine Sales in Türkiye (Turkey)

In 2023, the diabetes medicine market in Türkiye reached a value of 534.6 million USD. Since 2018, sales have shown consistent growth, achieving a compound annual growth rate (CAGR) of approximately 5.95% over the last five years. Year-on-year variations were recorded as follows: a decline of 4.8% in 2018, a jump of 15.81% in 2019, and a steady increase of 14.25% in 2020. The growth stabilized in recent years with slight increases of 0.99% for 2022 and 0.96% for 2023.

By 2028, the forecast indicates a steady rise in sales, with a five-year CAGR of 0.74%, marking a cumulative growth of 3.74% over this period.

Future trends to watch for include advancements in diabetes treatments, increased awareness and diagnosis rates, healthcare policy changes, and emerging market developments. Analyzing these factors could provide insights into further potential market expansions.